RecruitingNCT06526468

Chinese PE Multimodality Imaging Artificial Intelligence Study

CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study

Sponsor

China-Japan Friendship Hospital

Enrollment

1,500 participants

Start Date

Sep 1, 2010

Study Type

OBSERVATIONAL

Conditions

Pulmonary Embolism Chronic Thromboembolic Pulmonary Hypertension Chronic Thromboembolic Pulmonary Disease

Summary

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.

Eligibility

Min Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This study is using artificial intelligence (AI) and multiple types of imaging — including CT scans, ultrasound, and other methods — to improve the diagnosis of pulmonary embolism (PE), a potentially life-threatening condition where a blood clot blocks blood vessels in the lungs. The goal is to create AI tools that can detect PE faster and more accurately. **You may be eligible if...** - You are 14 years of age or older - You are suspected of having a pulmonary embolism and are undergoing imaging evaluation **You may NOT be eligible if...** - You are pregnant - You refuse to participate in follow-up - Your imaging scans were incomplete or not finished - The quality of your imaging data is too poor for analysis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.